The purpose of this study is to characterize CD86 receptor occupancy in subjects with rheumatoid arthritis (RA) receiving abatacept.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01339481?cond=%22Arthritis%22&lup_s=07/14/2011&lup_d=30
By ClinicalTrial.gov The purpose of this study is to characterize CD86 receptor occupancy in subjects with rheumatoid arthritis (RA) receiving abatacept.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01339481?cond=%22Arthritis%22&lup_s=07/14/2011&lup_d=30
The independent gateway for the orthopaedic community. Connecting professionals and patients since 1999.